Running Title: pDC development from common lymphoid progenitors 2 We identified a mouse pDC lineage derived exclusively from the common lymphoid progenitor (CLP) that is dependent on expression of Bcl1a. CLP-derived pDC have a unique gene expression profile that includes hallmark B cell genes not normally expressed in pDCs and therefore we refer to this lineage as "B-pDCs." Unlike classical pDC, B-pDC express an inherent activation signature, localize preferentially to secondary lymphoid organs and expand more robustly and also induce increased T cell proliferation relative to classical pDCs following Toll-like receptor 9 (TLR9) engagement. B-pDCs lack IFN-α secretion but instead express a distinct cytokine profile and display high levels of the cell-surface receptor tyrosine kinase Axl. Murine B-pDCs represent a CLPderived DC lineage that is genetically, phenotypically, and functionally homologous to an AXL + DC subtype recently discovered in human blood [1][2][3][4] .
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We identified a mouse pDC lineage derived exclusively from the common lymphoid progenitor (CLP) that is dependent on expression of Bcl1a. CLP-derived pDC have a unique gene expression profile that includes hallmark B cell genes not normally expressed in pDCs and therefore we refer to this lineage as "B-pDCs." Unlike classical pDC, B-pDC express an inherent activation signature, localize preferentially to secondary lymphoid organs and expand more robustly and also induce increased T cell proliferation relative to classical pDCs following Toll-like receptor 9 (TLR9) engagement. B-pDCs lack IFN-α secretion but instead express a distinct cytokine profile and display high levels of the cell-surface receptor tyrosine kinase Axl. Murine B-pDCs represent a CLPderived DC lineage that is genetically, phenotypically, and functionally homologous to an AXL + DC subtype recently discovered in human blood [1] [2] [3] [4] .
Plasmacytoid dendritic cells (pDCs) specialize in the production of type I interferons (IFNs) and promote antiviral immune responses following engagement of pattern recognition receptors. They have been implicated in the pathogenesis of autoimmune diseases that are characterized by a type I IFN signature (notably, IFN-α), yet pDC also can induce tolerogenic immune responses [5] [6] [7] [8] . Remarkably, considering the interest in pDC and their clinical significance, our understanding of pDC lineage derivation remains muddled. The transcription factor TCF4 is required for pDC development and for lineage identity 9-11 . TCF4 is a component of a multiprotein complex that includes both positive and negative regulators 6, 12 . One of these components, the transcription factor Bcl11a, which is also essential for B cell development [13] [14] [15] , induces
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Tcf4 expression and initiates a positive feedback loop with Tcf4 to maintain pDC lineage commitment and function [14] [15] [16] .
Unlike their conventional dendritic cell (cDC) counterparts, pDCs express multiple other transcriptional regulators and markers associated with B-lymphocyte development in addition to Bcl11a (e.g. B220, SpiB) 17, 18 . These features, along with established generation of pDC from myeloid restricted precursors, have made it difficult to define pDC lineage affiliation 11, 17, 19, 20 leading to the hypothesis that pDC may have distinct origins derived from either the Common Lymphoid Progenitor (CLP) or the Common Myeloid Progenitor (CMP) 18 . Beyond the enigmatic nature of their lineage derivation, pDCs with different functional attributes (e.g. variable IFN-α expression levels) or different surface markers (e.g. Cd19 + pDCs detected in tumor-draining lymph node) have also been identified 17, [21] [22] [23] . Recently, a novel dendritic cell (DC) population with pDC-like properties which can be identified by expression of the receptor tyrosine kinase AXL (AXL + DC) was discovered in human blood [1] [2] [3] [4] . While AXL + DCs express many "classical" pDC markers (CD123, BDCA2/CD303) they also express the Ig-like lectins SIGLEC1 and SIGLEC6, and the activation marker CD86 reduced by >50% in the KO mice (Fig. 1a, S2 ).
Next, we transferred BM from either Bcl11a-sufficient reporter control mice (mb1-Cre-YFP) or Bcl11a-deficient cKO mice (Bcl11a F/F mb1-Cre-YFP) into lethally irradiated C57BL/6 recipients. After 8 weeks, <6% of B cells in the spleens of mb1-Cre-YFP recipients were YFP -, confirming elimination of recipient hematopoiesis (Fig. 1b) .
As expected, Bcl11a F/F mb1-Cre-YFP BM resulted in significantly reduced B cell and pDC cellularity compared to mb1-Cre-YFP controls, whereas Bcl11a-sufficient (YFP  -) pDC persisted ( Fig. 1b and c, representative plots Fig. S2 ). Approximately 1/3 of pDCs in the spleen of wild-type chimeras were YFP + compared to only 1/5 in BM (Fig. 1d) .
This increased fraction of YFP + pDCs in the spleen suggests that CLP-derived pDC preferentially home to that organ. Other hematopoietic lineages were capable of development in normal numbers and contain a paucity of YFP + cells (Fig. 1e) . Of note, Bcl11a-deficient progenitors yielded higher splenic T cell chimerism at the expense of B (Fig. S1) .
Collectively, these results provide in vivo evidence for Bcl11a-dependent and BLP-derived pDCs (generated downstream of CLP) which populate the BM and periphery of adult mice. Because of their exclusive lymphoid derivation post T-B bifurcation, we were prompted hereafter to refer to this pDC lineage as "B-pDC." To further elucidate their phenotype at the genetic level, we performed RNA-seq analyses of purified B-pDC and compared them to classical, myeloid-derived pDC (Fig. 2a) . Purity of each population was confirmed as pDC by RT-PCR of shared pDC markers (Pdca1 and Bcl11a) (Fig. S3) . While the overall gene expression patterns were highly similar across the two subsets, ~1% of transcripts (~220 genes) differed significantly (q value < 0.05, Fig. 2b ). Differentially expressed transcripts generated Gene Ontology (GO) 27 or Panther 28 terms including "immune response", "inflammatory response", "cell activation", and "regulation of immune response" (p=1.36x10 -17 , 2.15x10 -12 , 3.67x10 -11 , and 1.45x10 -10 , respectively; Fig. S4 ). Gene set enrichment analysis (GSEA) revealed elevation of each of these same GO/Panther terms within the B-pDC subset as compared to a pDC-related GSEA control dataset that showed no enrichment (Fig. 2c) coupled with cell phenotyping by flow cytometry (Fig. 3a and b) , showed that B-pDCs express genes critical to early B cell biology. Cd19 was expressed at intermediate levels relative to B cells (Fig 2e, S5 ) and flow cytometry analysis revealed virtually all YFP + BpDC from mb1-Cre-YFP WT mice displayed Cd19 on their surface ( Fig. 3a and b) . In this same context, pre-B cell receptor components VpreB1 and Igll1/lambda5 were transcriptionally upregulated in B-pDCs (Fig. 2e) (Fig. 3b) .
Relative to classical pDC, resting Axl + B-pDC express higher levels of activation markers 30 MHC Class II, Cd83, and Cd86 (Fig 2e, 3a and (Fig 3c and d) . While both pDC and B-pDC compartments expanded relative to controls, the YFP + B-pDC fraction increased ~3-fold above that of the YFP -pDC fraction (~2.7x and ~7x expansion, respectively, Fig. 3d ).
Additionally B-pDC had markedly enhanced expression of MHC class II, Cd83, and
Cd86 levels upon activation, ( Fig. 3c and d) . These results indicate that, relative to classical pDC, B-pDC are intrinsically activated and primed for rapid expansion upon TLR9 engagement.
Ccr7 is strongly expressed upon activation of pDC by TLR9 engagement following CpG stimulation 31 , and such upregulation has been shown to be critical for chemotactic migration of activated DC into lymphoid organs for interaction with T To confirm the functional phenotype of B-pDC, we tested their ability to secrete cytokines known to be elicited by pDCs after Toll-like receptor (TLR) engagement.
Specifically, we tested each pDC lineage for the production of IFN-α or IL-12p40 when 8 activated by TLR9-binding CpG oligonucleotides. We sorted B-pDC and pDC, engaged TLR9 with CpG:ODNs for 24 hours and collected supernatant for cytokine specific
ELISAs. IFN-α production was almost negligible in B-pDC (p<0.0001, Fig. 3e ) yet IL12p40 production was significantly augmented over pDC (p<0.0001, Fig. 3f ), mirroring the functional phenotype of their human AXL + phenotypic counterparts 2 . That classical pDCs originally were identified as professional type I interferon-producing cells (IPC) 36 endowed with robust secretory machinery for the abundant secretion of cytokines, we speculate that B-pDC might instead utilize this attribute for copious secretion of alternative immune system modulators which they overexpress, such as C1q and Lyz ( Fig. S7) . We note that C1q can inhibit pDC production of IFN-α 37 .
To test their ability to expand T lymphocytes in culture, each were incubated with CpG:ODNs and co-cultured with freshly isolated CFSE-labeled lymphocytes. After 6 days, co-cultures were stained for CD3 and CFSE-negative cell percentages were recorded ( Fig. 3g) . B-pDCs were significantly better at expanding T cells in co-cultures (p=0.02, Fig. 3g and h including, intriguingly, BCL11A occupancy on its own promoter region in each cell line (Fig 4a and b) . In contrast, while B cells and pDC share numerous BCL11A targets, others are bound in a cell context-dependent fashion, including B cell only binding in PAX5, TCF3, and ID3 loci; CAL1 only binding in AXL, SIGLEC1, and IGLL1; and binding across cell types but with non-overlapping peaks in SPIB and ID2 (Fig. 4b) .
Dendritic cell-subset biology and development, and the ensuing nomenclature, have long been unclear. Here, we provide definitive evidence in support of the longsuspected "lymphoid past" of pDCs by establishing their ability to arise in vivo from CLP progenitors with B/pDC bipotential lineage capacity [17] [18] [19] 43, 44 . Our data suggest that the murine pDC compartment is bipartite, being comprised of B-pDC-diverted from the CLP post T-B bifurcation-as well as myeloid-derived classical pDC. One possible mechanism by which post-CLP B cell to B-pDC diversion might be achieved is suggested by elevated B-pDC expression of transcription factors Id2 and SpiC (Fig. 2e,   S5 ). Differentiation of the classical pDC is blocked by Id2 repression of Tcf4 activity 45 and driven by SpiB 46 . During B cell development, SpiC, which is highly related to SpiB, acts to both reduce B cell numbers 47 and to oppose SpiB-driven transcriptional regulation 48 . Once formed in the late CLP, mouse B-pDC exhibit additional canonical B cell genes; most notably Cd19, possibly displayed with help from high expression of the membrane tetraspanin Cd81, which is required for trafficking Cd19 to the surface in B cells 49 .
Recently, several groups have identified in human blood a new AXL + DC subset with distinct functions 1,2,4 . Although defined differently (Axl + Siglec1 + Siglec6 +1 vs.
Axl + Cd2 hi Cd81 +2,4 ), both definitions encompass the mouse B-pDC described here. Our study provides compelling evidence that the murine B-pDC is the homologue of this evolutionarily conserved DC subset. As with its human counterpart 3 , the B-pDC is found at higher frequency in the spleen than in the BM, indicating the possibility they preferentially home to secondary lymphoid organs. The mouse B-pDC also intrinsically express activation markers at higher levels, divide more rapidly after TLR9 engagement, and expand T cells more rapidly in culture than conventional pDCs, similar to AXL + DCs 2,4 . While further functional definition awaits discovery, our work provides a framework for the identification and segregation of the B-pDC lineage (comprising about 1/5 of the total pDC compartment) from its myeloid-derived counterpart(s). In particular,
we have elucidated the genetic, phenotypic, and functional conservation in mouse of the human counterpart AXL + DCs by using a lymphoid conditional knockout of the pDC transcription factor Bcl11a; and we have validated an experimental strategy for enriching Axl + DCs in wild-type or mb1-driven reporter mice, thereby providing a useful tool for the continued study of this novel pDC lineage.
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Our observations support the hypothesis that DC functionality derives primarily from ontogeny rather than from tissue environment 50 , exemplified by evolution of a specialized pDC lineage from a lymphoid progenitor. To date, the field of pDC biology has yet to identify a clonogenic progenitor restricted to the pDC compartment and perhaps that is because there is no single clonogenic progenitor for the present definition of pDC lineage, and that there are, at a minimum, two such progenitors for the pDC compartment. In the case of the B-pDC, our data suggest such a cell should exist within the late CLP, and may deviate from B cell commitment before or after Ly6d expression, thought to be the earliest marker of B cell specification 26 . Future experiments will address this question via refined cell sorting and expansion of CLP populations from mb1-driven reporter mice.
Plasmacytoid dendritic cells are thought to be involved in the pathogenesis of a variety of diseases, from autoimmune diseases to multiple treatment-resistant cancer types. For example, chronic activation of human pDC contributes to systemic lupus erythematosis, systemic sclerosis, and IFN-related autoimmune diseases 51, 52 . At the same time pDC have been shown to play an important role in normal immune tolerance as well as induce unwarranted immune tolerance in human cancers 51 . The demarcation of mouse B-pDCs may help clarify the perceived plasticity of the pDC compartment in normal and disease contexts 51 , and provides a new cell for targeted study within the context of autoimmune disease, cancer, and infection models.
Online Methods

Mice
Generation of Bcl11a cKO Mice was performed as described 14 . Mb1-Cre deleter and Rosa26-YFP reporter strains were obtained from Jackson labs (catalog #'s 020505 and 006148 , respectively).
Flow cytometry.
Analytical cytometry was performed on a FACS Fortessa and sorting was performed on a FACS Aria (BD Biosciences) followed by analysis using FlowJo (Tree Star) software.
For sorting prior to RNA collection, BM from 12 mice was prepared from femurs at 6 weeks of age, combined into three groups (4 mice/group), and single-cell suspensions were stained with antigen-specific monoclonal antibodies. Anti-mPDCA1-PE (Miltenyi Biotech), Anti-Cd45R/B220-V605, Anti-Cd19-Alexa Flour 700, Anti-Cd86-APC-Cy7, Anti-I-A/I-E-Pacific Blue, Anti-Cd179a-PE, Anti-IL7Ra-V421, Anti-cKit-PE-Cy7, AntiCd11b-PerCP-Cy5.5, Anti-Cd3e-PerCP-Cy5.5, Anti-Gr-1-PerCP-Cy5.5, Anti-Cd45R/ B220-PerCP-Cy5.5 Anti-Cd4-PerCP-Cy5.5, Anti-Cd8-PerCpCy5.5, Anti-NK1.1-PerCpCy5.5, Anti-Sca1-BV711, Anti-Cd135-APC, Anti-Cd150-BV605, Anti-Siglec1-PE-Cy7 
RNA isolation and RNA-seq
Total RNA was extracted from FACS sorted Bcl11a cKO BM pDC using TRIzol reagent with CFSE-labeled lymphocytes (2.5 × 10 4 ) for 6d with 20 units/mL of IL-2.
Enzyme-linked immunosorbent assays (ELISA).
BM from 6-week-old wildtype C57/BL6 mice was collected from femurs and B-pDC and pDC populations were segregated with a FACS Aria (BD Biosciences). Cells were stimulated with CpG-A (ODN 1585, Invivogen) or CpG-C (ODN 2395, Invivogen) and
ELISAs for IFN-α (Invitrogen) or IL-12p40 (BioLegend), respectively, were performed according to manufacturers recommendation.
ChIP followed by ChIP-seq
ChIP assays for BCL11A were performed and analyzed as described 14 . ChIP-seq data was analyzed by deep sequencing using Illumina sequencing technology as described above.
Data Deposition
RNA-seq: GSE105827; ChIP-seq: GSE99019
Accession numbers to previously published data sets: GSE52868 (pre-B RNA-seq);
GSE55043 (CAL1 ChIP-seq); ENCODE BCL11A ChIP-seq in GM12878 38 . (a) B220 + Pdca1 + Cd11b -pDC were consistently reduced in the cKO relative to littermate controls. As would be expected if pDC were partially generated from the CLP, pDC were reduced by 14-30% in the Bcl11aF/F/mb1-Cre+ cKO (p=0.0009), while B220 + Pdca1 -B-cell numbers were reduced by greater than 50% including loss of most B220 hi recirculating B cells which served as an indirect gauge of mb1-Cre deletion efficiency in vivo (p<0.0001) (Representative plots and summary table shown, n=6). 
References
